Clinical Trial Update: Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating clenbuterol for motor function in individuals with amyotrophic lateral sclerosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Clenbuterol

Snippet

Sponsor: Dwight Koeberl, M.D., Ph.D. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2022-09-06